-
2024
GlycoCaged N-heterocycles for improved treatment of inflammatory bowel diseases
Read MoreInflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis, is increasing in Canada and world-wide. IBD is painful and debilitating.…
-
Harry Brumer
Primary Investigator
-
-
A GlycoCaged drug delivery system to improve the treatment of inflammatory bowel disease
Read MoreInflammatory bowel disease (IBD) is lifelong, debilitating condition that afflicts one in every 150 Canadians. Worryingly, the number of people diagnosed with…
-
Harry Brumer
Primary Investigator
-